Ariely (adebrelimab)

SHR-8068-301: Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov)

Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC (clinicaltrials.gov)

A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (clinicaltrials.gov)

Prospective and exploratory clinical study on the efficacy and safety of Adebrelimab combined with chemotherapy as first-line treatment for unresectable locally advanced, recurrent, or metastatic neuroendocrine carcinoma of the digestive tract (ChiCTR2400088905)

Adebrelimab plus interventional and targeted therapy for unresectable hepatocellular carcinoma: a single-arm, real-world study (ChiCTR2400091083)

A multicenter, open-label, phase Ⅲ randomized controlled trial evaluating the efficacy and safety of adebrelimab in combination with chemotherapy and low-dose radiotherapy (LDRT) as first-line treatment for extensive-stage small cell lung cancer (SCLC) (ChiCTR2400090673)

Adebrelimab combined with irinotecan liposome, 5-fluorouracil, calcium folinate ± lenvatinib in first-line treatment of advanced intrahepatic cholangiocarcinoma:a prospective clinical study (ChiCTR2400089273)

Adebrelimab plus Chidamide in combination with Gemcitabine in patients with advanced squamous-cell non-small-cell lung cancer who previously progressed during or after treatment of PD-1 inhibitors (L-Aunching/SCOG-L003): A prospective, single-arm, exploratory trial (ChiCTR2400090083)

Drug-eluting Beads Transcatheter Arterial Chemoembolization Plus Adebrelimab and Apatinib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (TACT-01): A Single-arm, Exploratory Trial (ChiCTR2400090184)

To evaluate the efficacy and safety of NALIRIFOX combined with adbelimumab in the first-line treatment of unresectable locally advanced or metastatic biliary tract malignancies (ChiCTR2400089696)

Efficacy and safety of adebrelimab combined with lenvatinib as neoadjuvant therapy for resectable hepatocellular carcinoma: a randomized controlled open-label phase II study (ChiCTR2400080080)

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study (clinicaltrials.gov)

SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study. (PubMed, Front Immunol)

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer (clinicaltrials.gov)

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC (clinicaltrials.gov)

A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma (clinicaltrials.gov)

SHR-A1811-1316: SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in ER Positive/HER2 Low Breast Cancer (clinicaltrials.gov)

Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer (clinicaltrials.gov)

Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov)

A Study of HRS-4642 Monotherapy or in Combination with Adebrelimab in the Treatment of Advanced Biliary Tract Tumors. (clinicaltrials.gov)

A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer (clinicaltrials.gov)

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer. (clinicaltrials.gov)

Evaluating the Efficacy and Safety of Adebrelimab in Combination with Chemotherapy and LDRT As 1L Treatment for ES-SCLC (clinicaltrials.gov)

ACAC: Adebrelimab Combined With Capecitabine for Adjuvant Therapy in Cholangiocarcinoma With High-risk Recurrence Post-surgery (clinicaltrials.gov)

A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (clinicaltrials.gov)

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer (clinicaltrials.gov)

Exploratory study on the combination of Adebrelimab and Apatinib in the treatment of PD-1 inhibitor induced liver cancer (ChiCTR2400087077)

Adebrelimab (PD-L1) combined with gemcitabine and cisplatin (GP regimen) for unresectable advanced biliary tract cancer (ChiCTR2400087017)

Adebrelimab plus chemotherapy as first-line treatment in advanced first-line non-small cell lung cancer:a single arm ,phase 2 trial. (ChiCTR2400087166)

A single arm, prospective, exploratory study of Adebrelimab combined with lenvatinib and hepatic arterial infusion chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma (ChiCTR2400087024)

An exploratory clinical study of adebrelimab combined with chemotherapy and apatinib in first-line treatment of patients with extensive stage small cell lung cancer. (ChiCTR2400088296)

The conversion therapy for the stage III unresectable non-small cell lung cancer: a patient-oriented, prospective, open-label, multicentric, umbrella, phase II clinical trial (ChiCTR2400087339)

A Prospective, Multicenter Clinical Study of High- and Low-Dose Radiotherapy in Combination with Adebrelimab and Anlotinib for the Treatment of First-Line Failure/Recurrence of Driver-Negative Non-Small Cell Lung Cancer (ChiCTR2400088585)

An open, single-arm study of high-intensity focused ultrasound (HIFU) combined with Adebrelimab and XELIRI for the second-line treatment of locally advanced or metastatic pancreatic cancer (ChiCTR2400087021)

Clinical study of the effectiveness of adebelizumab in combination with the R-CHOP regimen for the first-line treatment of PD-L1-positive diffuse large B-cell lymphoma (ChiCTR2400088018)

Adebrelimab and Chidamide plus Gemcitabine as first-line treatment for advanced and metastatic pancreatic cancer patients (P-reCise/SCOG-P001): An exploratory, phase 2 trial. (ChiCTR2400079609)

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer (clinicaltrials.gov)

Adebrelimab Combined with Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer (clinicaltrials.gov)

A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced Malignancies (clinicaltrials.gov)

Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients (clinicaltrials.gov)

CAP 02: A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma (clinicaltrials.gov)

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors (clinicaltrials.gov)